This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Morigi C: Highlights from the15th St Gallen International Breast Cancer Conference 15–18 March, 2017, Vienna: tailored treatments for patients with early breast cancer. Ecancermedicalscience 2017; 11: 732.MorigiC:Highlights from the15th St Gallen International Breast Cancer Conference 15–18 March, 2017, Vienna: tailored treatments for patients with early breast cancer.2017;11:732.10.3332/ecancer.2017.732Search in Google Scholar
Giordano SH: Update on locally advanced breast cancer. Oncologist 2003; 8: 521–530.GiordanoSH:Update on locally advanced breast cancer.2003;8:521–530.10.1634/theoncologist.8-6-521Search in Google Scholar
Berruti A, Amoroso V, Gallo F, Bertaglia V, Simoncini E, Pedersini R et al.: Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: A meta-regression of 29 randomized prospective studies. J Clin Oncol 2014; 34: 3883–3891.BerrutiAAmorosoVGalloFBertagliaVSimonciniEPedersiniR:Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: A meta-regression of 29 randomized prospective studies.2014;34:3883–3891.10.1200/JCO.2014.55.2836Search in Google Scholar
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG): Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol 2018; 19: 27–39.Early Breast Cancer Trialists’ Collaborative Group (EBCTCG):Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.2018;19:27–39.10.1016/S1470-2045(17)30777-5Search in Google Scholar
Ogston KN, Miller ID, Payne S, Hutcheon AW, Sarkar TK, Smith I et al.: A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast 2003; 12: 320–327.OgstonKNMillerIDPayneSHutcheonAWSarkarTKSmithI:A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival.2003;12:320–327.10.1016/S0960-9776(03)00106-1Search in Google Scholar
Maur M, Guarneri V, Frassoldati A, Conte PF: Primary systemic therapy in operable breast cancer: clinical data and biological fall-out. Ann Oncol 2006; 17 (Suppl. 5): v158–v164.MaurMGuarneriVFrassoldatiAContePF:Primary systemic therapy in operable breast cancer: clinical data and biological fall-out.2006;17(Suppl. 5):v158–v164.10.1093/annonc/mdj97316807447Search in Google Scholar
Sachelarie I, Grossbard ML, Chadha M, Feldman S, Ghesani M, Blum RH: Primary systemic therapy of breast cancer. Oncologist 2006;11: 574–589.SachelarieIGrossbardMLChadhaMFeldmanSGhesaniMBlumRH:Primary systemic therapy of breast cancer.2006;11:574–589.10.1634/theoncologist.11-6-57416794237Search in Google Scholar
von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA et al.: Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 2012; 30: 1796–1804.von MinckwitzGUntchMBlohmerJUCostaSDEidtmannHFaschingPA:Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.2012;30:1796–1804.10.1200/JCO.2011.38.859522508812Search in Google Scholar
Dialani V, Chadashvili T, Slanetz PJ: Role of imaging in neoadjuvant therapy for breast cancer. Ann Surg Oncol 2015; 22: 1416–1424.DialaniVChadashviliTSlanetzPJ:Role of imaging in neoadjuvant therapy for breast cancer.2015;22:1416–1424.10.1245/s10434-015-4403-925727555Search in Google Scholar
Cocconi G, Di Blasio B, Alberti G, Bisagni G, Botti E, Peracchia G: Problems in evaluating response of primary breast cancer to systemic therapy. Breast Cancer Res Treat 1984; 4: 309–313.CocconiGDi BlasioBAlbertiGBisagniGBottiEPeracchiaG:Problems in evaluating response of primary breast cancer to systemic therapy.1984;4:309–313.10.1007/BF018060446549147Search in Google Scholar
Bosch AM, Kessels AG, Beets GL, Rupa JD, Koster D, van Engelshoven JM et al.: Preoperative estimation of the pathological breast tumor size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumours. Eur J Radiol 2003; 48: 285–292.BoschAMKesselsAGBeetsGLRupaJDKosterDvan EngelshovenJM:Preoperative estimation of the pathological breast tumor size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumours.2003;48:285–292.10.1016/S0720-048X(03)00081-0Search in Google Scholar
Keune JD, Jeffe DB, Schootman M, Hoffman A, Gillanders WE, Aft RL: Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer. Am J Surg 199: 477–484.KeuneJDJeffeDBSchootmanMHoffmanAGillandersWEAftRL:Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer.199:477–484.10.1016/j.amjsurg.2009.03.012325288920359567Search in Google Scholar
Corcioni B, Santilli L, Quercia S, Zamagni C, Santini D, Taffurelli M, Mignani S: Contrast-enhanced US and MRI for assessing the response of breast cancer to neoadjuvant chemotherapy. J Ultrasound 2008; 11: 143–150.CorcioniBSantilliLQuerciaSZamagniCSantiniDTaffurelliMMignaniS:Contrast-enhanced US and MRI for assessing the response of breast cancer to neoadjuvant chemotherapy.2008;11:143–150.10.1016/j.jus.2008.09.007355315623396645Search in Google Scholar
Evans A, Whelehan P, Thompson A, Purdie C, Jordan L, Macaskill J et al.: Prediction of pathological complete response to neoadjuvant chemotherapy for primary breast cancer comparing interim ultrasound, shear-wave elastography predict and MRI. Ultraschall Med 2017; 39: 422–431.EvansAWhelehanPThompsonAPurdieCJordanLMacaskillJ:Prediction of pathological complete response to neoadjuvant chemotherapy for primary breast cancer comparing interim ultrasound, shear-wave elastography predict and MRI.2017;39:422–431.10.1055/s-0043-11158928934812Search in Google Scholar
Evans A, Armstrong S, Whelehan P, Thomson K, Rauchhaus P, Purdie C et al.: Can shear-wave elastography predict response to neoadjuvant chemotherapy in women with invasive breast cancer? Br J Cancer 2013; 109: 2798–2802.EvansAArmstrongSWhelehanPThomsonKRauchhausPPurdieC:Can shear-wave elastography predict response to neoadjuvant chemotherapy in women with invasive breast cancer?2013;109:2798–2802.10.1038/bjc.2013.660384491324169359Search in Google Scholar
Ma Y, Zhang S, Li J, Jianyi Li, Kang Y, Ren W: Comparison of strain and shear-wave ultrasonic elastography in predicting the pathological response to neoadjuvant chemotherapy in breast cancers. Eur Radiol 2016; 27: 2282–2291.MaYZhangSLiJJianyiLiKangYRenW:Comparison of strain and shear-wave ultrasonic elastography in predicting the pathological response to neoadjuvant chemotherapy in breast cancers.2016;27:2282–2291.10.1007/s00330-016-4619-527752835Search in Google Scholar
Jing H, Cheng W, Li ZY, Ying L, Wang QCh, Wu T, Tian JW: Early evaluation of relative changes in tumor stiffness by shear wave elastography predicts the response to neodjuvant chemotherapy in patients with breast cancer. J Ultrasound Med 2016; 35: 1619–1627.JingHChengWLiZYYingLWangQChWuTTianJW:Early evaluation of relative changes in tumor stiffness by shear wave elastography predicts the response to neodjuvant chemotherapy in patients with breast cancer.2016;35:1619–1627.10.7863/ultra.15.0805227302898Search in Google Scholar
Hayashi M, Yamamoto Y, Ibusuki M, Fujiwara S, Yamamoto S, Tomita S et al.: Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer. Ann Surg Oncol 2012; 19: 3042–3049.HayashiMYamamotoYIbusukiMFujiwaraSYamamotoSTomitaS:Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer.2012;19:3042–3049.10.1245/s10434-012-2343-122476757Search in Google Scholar
Lobbes M, Prevos R, Smidt M: Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using breast MRI – a review of current knowledge. J Cancer Ther Res 2012; 1: 34–43.LobbesMPrevosRSmidtM:Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using breast MRI – a review of current knowledge.2012;1:34–43.10.7243/2049-7962-1-34Search in Google Scholar
Dialani V, Chadashvili T, Slanetz PJ: Role of imaging in neodjuvant therapy for breast cancer. Ann Surg Oncol 2015; 22: 1416–1424.DialaniVChadashviliTSlanetzPJ:Role of imaging in neodjuvant therapy for breast cancer.2015;22:1416–1424.10.1245/s10434-015-4403-925727555Search in Google Scholar
Sadeghi-Naini A, Papanicolau N, Falou O, Zubovits J, Dent R, Verma S et al.: Quantitative ultrasound evaluation of tumor cell death response in locally advanced breast cancer patients receiving chemotherapy. Clin Cancer Res 2013; 19: 2163–2174.Sadeghi-NainiAPapanicolauNFalouOZubovitsJDentRVermaS:Quantitative ultrasound evaluation of tumor cell death response in locally advanced breast cancer patients receiving chemotherapy.2013;19:2163–2174.10.1158/1078-0432.CCR-12-2965Search in Google Scholar
Brindle K: New approaches for imaging tumour responses to treatment. Nat Rev Cancer 2008; 8: 94–107.BrindleK:New approaches for imaging tumour responses to treatment.2008;8:94–107.10.1038/nrc2289Search in Google Scholar
Briffod M, Spyratos F, Tubiana-Hulin M, Pallud C, Mayras C, Filleul A, Rouëssé J: Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regression. Cancer 1989; 63: 631–637.BriffodMSpyratosFTubiana-HulinMPalludCMayrasCFilleulARouësséJ:Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regression.1989;63:631–637.10.1002/1097-0142(19890215)63:4<631::AID-CNCR2820630405>3.0.CO;2-WSearch in Google Scholar
Kennedy S, Merino MJ, Swain SM, Lippman ME: The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue. Hum Pathol 1990; 21: 192–198.KennedySMerinoMJSwainSMLippmanME:The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue.1990;21:192–198.10.1016/0046-8177(90)90128-RSearch in Google Scholar
Sadeghi-Naini A, Sannachi L, Tadayyon H, Tran W, Slodkowska E, Trudeau M et al.: Chemotherapy-response monitoring of breast cancer patients using quantitative ultrasound-based intra-tumour heterogeneities. Sci Rep 2017; 7: 10352.Sadeghi-NainiASannachiLTadayyonHTranWSlodkowskaETrudeauM:Chemotherapy-response monitoring of breast cancer patients using quantitative ultrasound-based intra-tumour heterogeneities.2017;7:10352.10.1038/s41598-017-09678-0Search in Google Scholar
Sannachi L, Tadayyon H, Sadeghi-Naini A, Tran W, Gandhi S, Wright F et al.: Non-invasive evaluation of breast cancer response to chemotherapy using quantitative ultrasonic backscatter parameters. Med Image Anal 2015; 20: 224–236.SannachiLTadayyonHSadeghi-NainiATranWGandhiSWrightF:Non-invasive evaluation of breast cancer response to chemotherapy using quantitative ultrasonic backscatter parameters.2015;20:224–236.10.1016/j.media.2014.11.009Search in Google Scholar
Tadayyon H, Sannachi L, Gangeh M, Sadeghi-Naini A, Tran W, Trudeau ME et al.: Quantitative ultrasound assessment of breast tumor response to chemotherapy using a multi-parameter approach. Oncotarget 2016; 7: 45094–45111.TadayyonHSannachiLGangehMSadeghi-NainiATranWTrudeauME:Quantitative ultrasound assessment of breast tumor response to chemotherapy using a multi-parameter approach.2016;7:45094–45111.10.18632/oncotarget.8862Search in Google Scholar
Oelze ML, Zachary JF, O’Brien WD Jr: Characterization of tissue microstructure using ultrasonic backscatter: theory and technique for opOelzeMLZacharyJFO’BrienWDJr:Search in Google Scholar